Merck & Co., Inc. (BVMF:MRCK34)

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of BRL 1.14 trillion. The enterprise value is 1.29 trillion.

Market Cap	1.14T
Enterprise Value	1.29T

Important Dates

The next estimated earnings date is Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	Jun 13, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.77%
Shares Change (QoQ)	-0.71%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.49B

Valuation Ratios

The trailing PE ratio is 12.79 and the forward PE ratio is 9.18.

PE Ratio	12.79
Forward PE	9.18
PS Ratio	3.30
PB Ratio	4.28
P/TBV Ratio	17.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.26, with an EV/FCF ratio of 16.07.

EV / Earnings	14.42
EV / Sales	3.72
EV / EBITDA	8.26
EV / EBIT	9.89
EV / FCF	16.07

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.72.

Current Ratio	1.42
Quick Ratio	0.82
Debt / Equity	0.72
Debt / EBITDA	1.23
Debt / FCF	2.40
Interest Coverage	18.77

Financial Efficiency

Return on equity (ROE) is 35.42% and return on invested capital (ROIC) is 18.04%.

Return on Equity (ROE)	35.42%
Return on Assets (ROA)	13.01%
Return on Invested Capital (ROIC)	18.04%
Return on Capital Employed (ROCE)	26.18%
Revenue Per Employee	4.68M
Profits Per Employee	1.21M
Employee Count	75,000
Asset Turnover	0.55
Inventory Turnover	2.20

Taxes

In the past 12 months, Merck & Co. has paid 14.95 billion in taxes.

Income Tax	14.95B
Effective Tax Rate	14.32%

Stock Price Statistics

The stock price has decreased by -28.63% in the last 52 weeks. The beta is 0.39, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	-28.63%
50-Day Moving Average	56.22
200-Day Moving Average	63.36
Relative Strength Index (RSI)	48.20
Average Volume (20 Days)	2,734

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.81

Income Statement

In the last 12 months, Merck & Co. had revenue of BRL 346.63 billion and earned 89.39 billion in profits. Earnings per share was 35.34.

Revenue	346.63B
Gross Profit	268.33B
Operating Income	130.49B
Pretax Income	104.42B
Net Income	89.39B
EBITDA	154.36B
EBIT	130.49B
Earnings Per Share (EPS)	35.34

Balance Sheet

The company has 46.98 billion in cash and 192.90 billion in debt, giving a net cash position of -145.92 billion.

Cash & Cash Equivalents	46.98B
Total Debt	192.90B
Net Cash	-145.92B
Net Cash Per Share	n/a
Equity (Book Value)	267.32B
Book Value Per Share	106.65
Working Capital	60.09B

Cash Flow

In the last 12 months, operating cash flow was 100.99 billion and capital expenditures -20.77 billion, giving a free cash flow of 80.22 billion.

Operating Cash Flow	100.99B
Capital Expenditures	-20.77B
Free Cash Flow	80.22B
FCF Per Share	n/a

Margins

Gross margin is 77.41%, with operating and profit margins of 37.64% and 25.79%.

Gross Margin	77.41%
Operating Margin	37.64%
Pretax Margin	30.12%
Profit Margin	25.79%
EBITDA Margin	44.53%
EBIT Margin	37.64%
FCF Margin	23.14%

Dividends & Yields

This stock pays an annual dividend of 1.56, which amounts to a dividend yield of 2.73%.

Dividend Per Share	1.56
Dividend Yield	2.73%
Dividend Growth (YoY)	18.42%
Years of Dividend Growth	2
Payout Ratio	4.41%
Buyback Yield	0.77%
Shareholder Yield	3.46%
Earnings Yield	7.82%
FCF Yield	7.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 8.

Last Split Date	Oct 29, 2020
Split Type	Forward
Split Ratio	8

Scores

Merck & Co. has an Altman Z-Score of 4.33 and a Piotroski F-Score of 6.

Altman Z-Score	4.33
Piotroski F-Score	6